<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Greater visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>, higher <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, and <z:e sem="disease" ids="C0948379" disease_type="Disease or Syndrome" abbrv="">impaired insulin secretion</z:e> increase the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Whether visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> increases risk of <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) independent of other adipose depots, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, and insulin secretion is not known </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: Study subjects included 128 Japanese Americans with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance at entry </plain></SENT>
<SENT sid="3" pm="."><plain>Baseline variables included plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin measured after an overnight fast and during a 75-g oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test, fat areas by computed tomography, insulin secretion (incremental insulin response [IIR] [30 min insulin - fasting insulin]/30 min <z:chebi fb="105" ids="17234">glucose</z:chebi>), and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> index (homeostasis model assessment for <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> [HOMA-IR]) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: During the 10- to 11-year follow-up period, we confirmed 57 cases of IGT </plain></SENT>
<SENT sid="5" pm="."><plain>Significant predictors of IGT included intra-abdominal fat area (IAFA) (odds ratio [OR] for a 1 SD increase 3.82, 95% CI 1.63-8.94 at a fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> [FPG] level of 4.5 mmol/l), HOMA-IR (2.41, 1.15-5.04), IIR (0.30, 0.13-0.69 at an FPG level of 4.5 mmol/l), the interactions of IAFA by FPG (P = 0.003), and IIR by FPG (P = 0.030) after adjusting for age, sex, FPG, and BMI </plain></SENT>
<SENT sid="6" pm="."><plain>The multiple-adjusted OR of IAFA increased and that of IIR decreased as FPG level decreased because of these interactions </plain></SENT>
<SENT sid="7" pm="."><plain>Even after adjustment for total fat area, total subcutaneous fat area, or abdominal subcutaneous fat area, <z:hpo ids='HP_0000001'>all</z:hpo> of these associations remained a significant predictor of IGT incidence </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Greater visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> increases the risk of IGT independent of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, insulin secretion, and other adipose depots in Japanese Americans </plain></SENT>
</text></document>